This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1syv

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1syv.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1syv.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1syv| PDB=1syv | SCENE= }}
{{STRUCTURE_1syv| PDB=1syv | SCENE= }}
-
'''HLA-B*4405 complexed to the dominant self ligand EEFGRAYGF'''
+
===HLA-B*4405 complexed to the dominant self ligand EEFGRAYGF===
-
==Overview==
+
<!--
-
HLA class I polymorphism creates diversity in epitope specificity and T cell repertoire. We show that HLA polymorphism also controls the choice of Ag presentation pathway. A single amino acid polymorphism that distinguishes HLA-B*4402 (Asp116) from B*4405 (Tyr116) permits B*4405 to constitutively acquire peptides without any detectable incorporation into the transporter associated with Ag presentation (TAP)-associated peptide loading complex even under conditions of extreme peptide starvation. This mode of peptide capture is less susceptible to viral interference than the conventional loading pathway used by HLA-B*4402 that involves assembly of class I molecules within the peptide loading complex. Thus, B*4402 and B*4405 are at opposite extremes of a natural spectrum in HLA class I dependence on the PLC for Ag presentation. These findings unveil a new layer of MHC polymorphism that affects the generic pathway of Ag loading, revealing an unsuspected evolutionary trade-off in selection for optimal HLA class I loading versus effective pathogen evasion.
+
The line below this paragraph, {{ABSTRACT_PUBMED_15226359}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 15226359 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_15226359}}
==Disease==
==Disease==
Line 45: Line 49:
[[Category: Hla]]
[[Category: Hla]]
[[Category: Mhc]]
[[Category: Mhc]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 09:17:31 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 15:47:59 2008''

Revision as of 12:48, 29 July 2008

Image:1syv.png

Template:STRUCTURE 1syv

Contents

HLA-B*4405 complexed to the dominant self ligand EEFGRAYGF

Template:ABSTRACT PUBMED 15226359

Disease

Known disease associated with this structure: Hypoproteinemia, hypercatabolic OMIM:[109700]

About this Structure

1SYV is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion., Zernich D, Purcell AW, Macdonald WA, Kjer-Nielsen L, Ely LK, Laham N, Crockford T, Mifsud NA, Bharadwaj M, Chang L, Tait BD, Holdsworth R, Brooks AG, Bottomley SP, Beddoe T, Peh CA, Rossjohn J, McCluskey J, J Exp Med. 2004 Jul 5;200(1):13-24. Epub 2004 Jun 28. PMID:15226359

Page seeded by OCA on Tue Jul 29 15:47:59 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1syv"
Personal tools